Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 262 results for "sun pharma"

No major respite for Sun Pharma
Business Standard

No major respite for Sun Pharma

The Sun Pharmaceutical stock, after seeing some gains post September quarter results, is now marginally below pre-result levels despite the recent positive news flow. So, what's keeping sentiment low in the counter?First the positive part. The latest ... Business Standard, 1 week ago

98 images for sun pharma

Sify, 2 weeks ago
Money Today, 3 weeks ago
Money Today, 3 weeks ago
Business Standard, 3 weeks ago
Business Standard, 7 hours ago
Business Standard, 7 hours ago
Money Control, 2 weeks ago
Business Standard, 3 weeks ago
Money Control, 1 month ago
Money Control, 4 days ago

Closing Bell: Sensex ends 118 pts higher, Nifty above 10,300; pharma soars

DRL, Sun Pharma and Cipla were the top gainers, while Coal India, Kotak Mahindra and Indiabulls Housing lost the most.
 Money Control1 week ago Closing Bell: Sensex ends on a positive note, Nifty below 10350; Infosys up 3%  Money Control1 week ago Closing bell: Sensex slips 92 pts, Nifty ends below 10,200 on weak Asian cues  Money Control3 weeks ago Closing bell: Sensex ends up 112 pts, Nifty ends above 10,450 for first time  Money Control1 month ago
Business Standard

How desi brothers built a $1.8 bn drug co

Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das. Illustration: Dominic Xavier/Rediff.com. Two Indian-American brothers hailing from Gujarat, Chirag and Chintu Patel, have built a $1.8-billion drug major Amneal Pharmaceuticals in the US from scratch in around a decade and a half. After its recent merger with Impax Laboratories last month, the combined entity, with revenues of $1.75-1.85 billion, is close to pipping Indian giant ...
 Rediff.com1 week ago Founded by 2 Gujaratis, US drug major Amneal eyes speciality biz in India  Business Standard2 weeks ago
Sify

Sun Pharma in focus after recall of product

Sun Pharmaceutical Industries (Sun Pharma) said it is recalling two lots of Riomet (Metformin Hydrochloride Oral Solution), 500 mg/5ml, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet has ...
 Business Standard2 weeks ago Sun Pharma drops after recall of product  Business Standard2 weeks ago Sun Pharma slides on recall of diabetes drug  Sify2 weeks ago BUZZ-India's Sun Pharmaceutical Industries falls on weak Q2 earnings  Sify3 weeks ago
Money Today

Sun Pharma records Rs 912 crore profit, 59% dip in Q2

BT Online New Delhi Last Updated: November 14, 2017 | 17:51 IST Pharma major Sun Pharmaceutical Industries said today its consolidated net profit dropped by 59.19 per cent to Rs 912.12 crore for the quarter ended on September 30, 2017, compared to the ...
 Money Today3 weeks ago Sun Pharma drops after reporting weak Q2 results  Business Standard3 weeks ago Sun Pharma may slide after weak Q2 outcome  Business Standard3 weeks ago Sun Pharma plunges 3% on weak Q2 nos; Morgan Stanley underweight with target Rs 448  Money Control3 weeks ago
Money Control

Market Update: CNX Pharma outperforms led by Dr Reddy#39;s , Sun Pharma; RComm zooms over 11%

CNX Pharma zoomed over 2 percent and was distinctively the outperforming sector led by Dr Reddy#39;s Labs and Sun Pharma which jumped over 3 percent each while Cipla and Lupin were the other top pharma gainers.
 Money Control3 weeks ago Price-fixing allegations, a new worry to deal with for some leading Indian pharma companies in the US  Money Today1 month ago DRL, Sun, Glenmark among 18 under US lens on price fixing  Business Standard1 month ago Four pharma firms face US price-fixing charge  Business Standard1 month ago
[x]  
Money Control

Market Update: Sun Pharma, Infratel top Nifty gainers; Rain Industries zooms 4%, JSPL hits 52-week high

Bharti Infratel which gained 1.63 percent while Sun Pharma added 1.32 percent along with Ambuja Cements, Eicher Motors and Aurobindo Pharma were the top Nifty gainers.
 Money Control2 weeks ago Market Update: JP Associates tanks over 10%, RComm hits 52-week low; RIL top Nifty gainer  Money Control3 weeks ago Market Update: Jubilant Food, Voltas hit new 52-week high; BoB up over 2%, Vedanta top loser  Money Control3 weeks ago This week in pharma: Sun Pharma get EIR for Dadra plant, Lupin acquires Symbiomix Therapeutics  Money Control1 month ago
Money Control

Stocks in the news: Sun Pharma, BoB, Havells, Airtel, Simplex Infra, Britannia, GSPL

Sun Pharma | Bank of Baroda | Eicher Motors | Havells India | Bharti Airtel | Simplex Infra | Britannia | Petronet LNG | Vakrangee | Gujarat State Petronet | United Bank Of India | Repco Home Finance | Adani Enterprises | Shalimar Paints | Jindal Poly and JK ...
 Money Control4 weeks ago Market Update: Cipla gains over 3%; Axis Bank hits 52-week high, Bharti Airtel most active  Money Control1 month ago Market update: Bharti Airtel, Cipla hit new 52-week high; ICICI, SBI, Sun Pharma most active  Money Control1 month ago Market update: Pharma stocks rally as Divis zooms over 16%; ICICI hits new 52-week high  Money Control1 month ago
Business Standard

Sun Pharma recalls diabetes drug in US over microbial contamination

Use of contaminated Riomet potentially could result in a risk of infection, especially in the immunocompromised patient. Last Updated at November 24, 2017 21:19 IST Sun Pharma today said its US- based subsidiary is recalling two lots of diabetes drug Riomet ...
 Business Standard2 weeks ago Sun Pharma recalls 2 lots of diabetes drug Riomet in US  Money Control2 weeks ago
Business Standard

Sun Pharma shares dip 4%, m-cap drops by Rs 5,065 cr as Q2 net declines 59%

The scrip was the worst hit among the 30 Sensex blue chips Last Updated at November 15, 2017 16:32 IST Shares of Sun Pharmaceutical Industries on Wednesday ended 4 per cent lower after the company reported a 59.19 per cent decline in consolidated net profit ...
 Business Standard3 weeks ago Sun Pharma shares drop over 3% after Q2 earnings  Business Standard3 weeks ago Sun Pharma shares up nearly 3%; mcap rises by Rs 3,260 cr  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less